The Holmium Platform: Three integrated products delivering individualised SIRT at its full potential

669
This educational supplement, sponsored by Terumo Interventional Systems, is intended for readers in Europe only.
Highlights:
  • Ana Oliveira (Centro Hospitalar Universitário de São João, Porto, Portugal) discusses experiences of adopting The Holmium Platform at her centre
  • Irene Bargellini (Pisa University Hospital, Pisa, Italy) outlines the intentions of the iHEPAR study
  • Kees Punt (Julius Center UMC Utrecht, Utrecht, The Netherlands) discusses the CAIRO7 study and the potential impact should it produce positive results
  • Lambros Tselikas and Thierry De Baere provide an overview of the upcoming HOLM-Brave study

LEAVE A REPLY

Please enter your comment!
Please enter your name here